Search

everythinglearnresearchcommunity

for

Search:↓

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

These new skin treatments are safer and more effective with minimal side effects.

Five FDA-approved drugs may help block COVID-19 virus entry.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Finasteride increases CD8+ T cells in BPH tissues.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Metformin may help treat neuroendocrine tumors.

Apple polyphenol, especially oligomeric procyanidins, can reduce fat absorption and lower blood fat levels.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

KAP-depleted hair causes less immune response and is more biocompatible for implants.

The treatment increased total hair count but wasn't significantly better than placebo.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

Increased energy use in Pik3r1-related insulin resistance isn't due to Ucp1 thermogenesis.

4-aminopyridine speeds up and improves skin wound healing.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.